marijuana stocks news

Advanced Cannabis Solutions, Inc. (CANN)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013
Total Revenue 14   49   (22) –  
Cost of Revenue (15) (12)
Gross Profit 29   49   (9) –  
Operating Expenses
Research Development
Selling General and Administrative 1,342 961 383 313
Non Recurring
Others 13 3
Total Operating Expenses
Operating Income or Loss (1,325) (915) (392) (313)
Income from Continuing Operations
Total Other Income/Expenses Net (346) (953) 149 (150)
Earnings Before Interest And Taxes (1,671) (1,869) (243) (463)
Interest Expense 76 50 1
Income Before Tax (1,747) (1,919) (244) (463)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,747) (1,919) (244) (463)
Non-recurring Events
Discontinued Operations 2 11 (9)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,747) (1,917) (233) (472)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,747) (1,917) (233) (472)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reliq Health Technologies Inc. (RQHTF) Announces Strategic Alliance with iDocsWeb to Offer its iUGO Care platform

Reliq Health Technologies, Inc. Announces Strategic Alliance with iDocsWeb to Offer its…

$PDLI Completes Royalty Transaction with ARIAD Pharmaceuticals

PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals  PDL BioPharma, Inc. (PDLI)…

Trulieve Cannabis Corp. (TCNNF) to Hold First Quarter 2023 Results Conference Call on May 10, 2023

Trulieve Cannabis Corp. to Hold First Quarter 2023 Results Conference Call on…

AbbVie (ABBV) Receives Positive CHMP Opinion for VENCLYXTO® (venetoclax)

AbbVie Receives Positive CHMP Opinion for VENCLYXTO® (venetoclax) as a Combination Regimen…